Overview

Study of ACE-011 for the Treatment of Chemotherapy Induced Anemia in Patients With Metastatic Breast Cancer

Status:
Terminated
Trial end date:
2010-11-18
Target enrollment:
Participant gender:
Summary
Anemia can be caused by the chemotherapy treatment that is used to treat metastatic breast cancer. This study will be used to find out if ACE-011 can help treat chemotherapy induced anemia in patients with metastatic breast cancer.
Phase:
Phase 2
Details
Lead Sponsor:
Celgene
Celgene Corporation